Search details
1.
Pembrolizumab for the treatment of non-small-cell lung cancer.
N Engl J Med
; 372(21): 2018-28, 2015 May 21.
Article
in English
| MEDLINE | ID: mdl-25891174
2.
Identification of a novel RAMP-independent CGRP receptor antagonist.
Bioorg Med Chem Lett
; 21(22): 6705-8, 2011 Nov 15.
Article
in English
| MEDLINE | ID: mdl-21982500
3.
Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Eur J Pharmacol
; 434(1-2): 49-53, 2002 Jan 02.
Article
in English
| MEDLINE | ID: mdl-11755165
4.
A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.
Clin Vaccine Immunol
; 15(2): 314-9, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18077611
5.
Caprolactams as potent CGRP receptor antagonists for the treatment of migraine.
Bioorg Med Chem Lett
; 17(17): 4795-8, 2007 Sep 01.
Article
in English
| MEDLINE | ID: mdl-17616394
6.
Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: optimization of the 4-substituted piperidine.
Bioorg Med Chem Lett
; 16(19): 5052-6, 2006 Oct 01.
Article
in English
| MEDLINE | ID: mdl-16889959
7.
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead.
Bioorg Med Chem Lett
; 16(10): 2595-8, 2006 May 15.
Article
in English
| MEDLINE | ID: mdl-16527483
8.
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.
Bioorg Med Chem Lett
; 14(11): 2941-5, 2004 Jun 07.
Article
in English
| MEDLINE | ID: mdl-15125964
9.
Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR.
Bioorg Med Chem Lett
; 13(15): 2485-8, 2003 Aug 04.
Article
in English
| MEDLINE | ID: mdl-12852948
10.
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitors.
Bioorg Med Chem Lett
; 12(19): 2767-70, 2002 Oct 07.
Article
in English
| MEDLINE | ID: mdl-12217372
11.
Discovery and evaluation of 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as a novel class of KDR kinase inhibitors.
Bioorg Med Chem Lett
; 13(18): 2973-6, 2003 Sep 15.
Article
in English
| MEDLINE | ID: mdl-12941314
12.
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.
Bioorg Med Chem Lett
; 12(24): 3537-41, 2002 Dec 16.
Article
in English
| MEDLINE | ID: mdl-12443771
Results
1 -
12
de 12
1
Next >
>>